SELLAS Life Sciences Group, Inc. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

SELLAS Life Sciences Group, Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $0.00 for the year ending 2023.

  • SELLAS Life Sciences Group, Inc. showed a decrease of -100.0% in Revenue From Contract With Customer Excluding Assessed Tax from 2022 to 2023.
  • This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 28, 2024.
  • XBRL data for this metric is available from 2019 to 2023 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2023: $0.00 | Fiscal year 2022: $1.00 million | Fiscal year 2021: $7.60 million | Fiscal year 2020: $1.90 million | Fiscal year 2019: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: